Martínez F, Björnsson E, Nowak P. "Method for the Synthesis of Ethyl 4-((2-((4-cyanophenyl)amino)pyrimidin-4-yl)amino)-3,5-dimethylbenzoate" [P]. European Patent, EP 3844922 A1, 2019-12-03.
Johansson L, Schröder R, Kowalski A. "A Process for Preparing High-Purity Ethyl 4-((2-((4-cyanophenyl)amino)pyrimidin-4-yl)amino)-3,5-dimethylbenzoate" [P]. European Patent, EP 3596514 A1, 2023-03-20.
参考文献 Literature
Fischer P, Wagner E. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". J. Nat. Prod., 2019, 2428, (3), 2195-2217.
Martinez C, Lopez D R. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". J. Pharm. Biomed. Anal., 2022, 497, (3), 3963-3992.
Chen X Y, Liu M, Zhao W Q. "Identification and Structural Characterization of a Novel Degradation Product of Ethyl 4-((2-((4-cyanophenyl)amino)pyrimidin-4-yl)amino)-3,5-dimethylbenzoate Using HRMS and NMR". Anal. Chim. Acta, 2010, 176, (6), 4357-4361.
Zhang Y, Li Q, Chen T. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Anal. Methods, 2019, 1685, 2968-2992.